22
Views
51
CrossRef citations to date
0
Altmetric
Cell Growth and Development

IRS-4 Mediates Protein Kinase B Signaling during Insulin Stimulation without Promoting Antiapoptosis

, &
Pages 126-138 | Received 15 Mar 1999, Accepted 27 Sep 1999, Published online: 28 Mar 2023
 

Abstract

Insulin receptor substrate (IRS) proteins are tyrosine phosphorylated and mediate multiple signals during activation of the receptors for insulin, insulin-like growth factor 1 (IGF-1), and various cytokines. In order to distinguish common and unique functions of IRS-1, IRS-2, and IRS-4, we expressed them individually in 32D myeloid progenitor cells containing the human insulin receptor (32DIR). Insulin promoted the association of Grb-2 with IRS-1 and IRS-4, whereas IRS-2 weakly bound Grb-2; consequently, IRS-1 and IRS-4 enhanced insulin-stimulated mitogen-activated protein kinase activity. During insulin stimulation, IRS-1 and IRS-2 strongly bound p85α/β, which activated phosphatidylinositol (PI) 3-kinase, protein kinase B (PKB)/Akt, and p70s6k, and promoted the phosphorylation of BAD. IRS-4 also promoted the activation of PKB/Akt and BAD phosphorylation during insulin stimulation; however, it weakly bound or activated p85-associated PI 3-kinase and failed to mediate the activation of p70s6k. Insulin strongly inhibited apoptosis of interleukin-3 (IL-3)-deprived 32DIR cells expressing IRS-1 or IRS-2 but failed to inhibit apoptosis of cells expressing IRS-4. Consequently, 32DIR cells expressing IRS-4 proliferated slowly during insulin stimulation. Thus, the activation of PKB/Akt and BAD phosphorylation might not be sufficient to inhibit the apoptosis of IL-3-deprived 32DIR cells unless p85-associated PI 3-kinase or p70s6k are strongly activated.

ACKNOWLEDGMENTS

This work was supported by DK38712 (M.F.W.) and Juvenile Diabetes Foundation Research grant 197043 (M.G.M.). T.U. was supported by an American Diabetes Association Mentor-Based Fellowship and the Nakatomi Foundation Research Grant from Japan.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.